New Drug Study Revives Debate Over Prostate Cancer Screening
Robert Siegel speaks with Dr. Michael LeFevre, professor at University of Missouri Medical school and co-vice chair of the United States Preventive Services Task Force, about how the new drug study revives a debate over the need for a controversial prostate cancer screening tool, the PSA test.